The 21st series of the eChallenges conference
takes place in the beautiful city of Florence, Italy from 26-28 October 2011. The conference attracts over 600 delegates from leading commercial, government and research organisations around the world to share knowledge and experience, lessons learnt, good practice and innovation.
We are very glad to present there results from ImaGeo in a full technical paper titled: Leveraging geo-tagged media for mobile eTourism – an integrated scenario
Mark the day and register by 31 July to benefit from early bird rates! We look forward to seeing you in Florence.
IN2 is exhibiting ImaGeo
at the Heidelberg Innovation Forum
on 12 April 2011. The forum is an initiative of the Innovation Agency for ICT and Media (MFG)
in Baden-Württemberg and the European Media Laboratory (EML)
The focus in 2011 is on Immersive Technologies. The Heidelberg Innovation Forum has succeeded in bringing together ICT researchers and market players in the early phases of innovation. The matchmaking platform supports start-up financing, licensing and R&D cooperation.
Contact us at firstname.lastname@example.org for an appointment. We look forward to seeing you in Heidelberg!
Today we announce that the ImaGeo beta portal
is up and available! You are invited to read the related presentation
on its features, try it out for yourself and give us feedback by taking a quick survey
We are excited to present the ImaGeo beta portal to you and look forward to your comments at email@example.com.
The ImaGeo field trials in Siena were a success! We received local news coverage and welcomed representatives from the press, municipal service and technology providers and general Siena residents. We presented
the ImaGeo system and also carried out a number of city tours
around the Piazza del Campo to demonstrate its capabilities. The participants were excited by its potential and are looking forward to its release on the market.
Read the Italian article and see the video on SIENANEWS; download the English press release on the field trials.